In March 2025, the company announced new options for just a immediate-to-shopper presenting of its Wegovy weight loss drug. The company founded a different pharmacy, referred to as NovoCare, which might cost shoppers $499 monthly for usage of the drug, under half the cost of the drug by way of other pharmaceutical distribution networks.[fifty three